Rediffmail Money Enterprise Email Business Email rediffGURUS Rediff-TV

Sign in
Create Account

News for 'Exelan Pharmaceuticals Inc'

Cipla to acquire two US-based pharma cos for $550 million

Cipla to acquire two US-based pharma cos for $550 million

Rediff.com4 Sep 2015

Cipla has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million.

Rediffmail for Work Book a domain Rediffmail Money Videos The Timeless 100

NEWS

BUSINESS

MOVIES

CRICKET

SPORTS

GET AHEAD

REDIFF MONEY

REDIFF-TV

REDIFF ASTRO